807 related articles for article (PubMed ID: 25937281)
21. Homology arms of targeting vectors for gene insertions and CRISPR/Cas9 technology: size does not matter; quality control of targeted clones does.
Petrezselyova S; Kinsky S; Truban D; Sedlacek R; Burtscher I; Lickert H
Cell Mol Biol Lett; 2015 Dec; 20(5):773-87. PubMed ID: 26540224
[TBL] [Abstract][Full Text] [Related]
22. Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones.
Frank E; Cailleret M; Nelep C; Fragner P; Polentes J; Herardot E; El Kassar L; Giraud-Triboult K; Monville C; Ben M'Barek K
Stem Cell Res Ther; 2023 Apr; 14(1):110. PubMed ID: 37106426
[TBL] [Abstract][Full Text] [Related]
23. High-efficiency non-mosaic CRISPR-mediated knock-in and indel mutation in F0
Aslan Y; Tadjuidje E; Zorn AM; Cha SW
Development; 2017 Aug; 144(15):2852-2858. PubMed ID: 28694259
[TBL] [Abstract][Full Text] [Related]
24. One-Step Generation of Seamless Luciferase Gene Knockin Using CRISPR/Cas9 Genome Editing in Human Pluripotent Stem Cells.
Li M; Hunt JFVS; Bhattacharyya A; Zhao X
Methods Mol Biol; 2019; 1942():61-69. PubMed ID: 30900175
[TBL] [Abstract][Full Text] [Related]
25. Efficient RNA/Cas9-mediated genome editing in Xenopus tropicalis.
Guo X; Zhang T; Hu Z; Zhang Y; Shi Z; Wang Q; Cui Y; Wang F; Zhao H; Chen Y
Development; 2014 Feb; 141(3):707-14. PubMed ID: 24401372
[TBL] [Abstract][Full Text] [Related]
26. Efficient genome editing by FACS enrichment of paired D10A Cas9 nickases coupled with fluorescent proteins.
Gopalappa R; Song M; Chandrasekaran AP; Das S; Haq S; Koh HC; Ramakrishna S
Arch Pharm Res; 2018 Sep; 41(9):911-920. PubMed ID: 29855892
[TBL] [Abstract][Full Text] [Related]
27. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.
Vojnits K; Nakanishi M; Porras D; Kim Y; Feng Z; Golubeva D; Bhatia M
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458632
[TBL] [Abstract][Full Text] [Related]
28. Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9.
Chen Y; Cao J; Xiong M; Petersen AJ; Dong Y; Tao Y; Huang CT; Du Z; Zhang SC
Cell Stem Cell; 2015 Aug; 17(2):233-44. PubMed ID: 26145478
[TBL] [Abstract][Full Text] [Related]
29. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.
Ihry RJ; Worringer KA; Salick MR; Frias E; Ho D; Theriault K; Kommineni S; Chen J; Sondey M; Ye C; Randhawa R; Kulkarni T; Yang Z; McAllister G; Russ C; Reece-Hoyes J; Forrester W; Hoffman GR; Dolmetsch R; Kaykas A
Nat Med; 2018 Jul; 24(7):939-946. PubMed ID: 29892062
[TBL] [Abstract][Full Text] [Related]
30. Multiple genome modifications by the CRISPR/Cas9 system in zebrafish.
Ota S; Hisano Y; Ikawa Y; Kawahara A
Genes Cells; 2014 Jul; 19(7):555-64. PubMed ID: 24848337
[TBL] [Abstract][Full Text] [Related]
31. Design and Derivation of Multi-Reporter Pluripotent Stem Cell Lines via CRISPR/Cas9n-Mediated Homology-Directed Repair.
Dettmer R; Naujok O
Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e116. PubMed ID: 32628328
[TBL] [Abstract][Full Text] [Related]
32. Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.
Xu P; Tong Y; Liu XZ; Wang TT; Cheng L; Wang BY; Lv X; Huang Y; Liu DP
Sci Rep; 2015 Jul; 5():12065. PubMed ID: 26156589
[TBL] [Abstract][Full Text] [Related]
33. Fast and Quantitative Identification of Ex Vivo Precise Genome Targeting-Induced Indel Events by IDAA.
König S; Yang Z; Wandall HH; Mussolino C; Bennett EP
Methods Mol Biol; 2019; 1961():45-66. PubMed ID: 30912039
[TBL] [Abstract][Full Text] [Related]
34. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
[TBL] [Abstract][Full Text] [Related]
35. Tandem Paired Nicking Promotes Precise Genome Editing with Scarce Interference by p53.
Hyodo T; Rahman ML; Karnan S; Ito T; Toyoda A; Ota A; Wahiduzzaman M; Tsuzuki S; Okada Y; Hosokawa Y; Konishi H
Cell Rep; 2020 Jan; 30(4):1195-1207.e7. PubMed ID: 31995758
[TBL] [Abstract][Full Text] [Related]
36. Generating CRISPR-Cas9-Mediated Null Mutations and Screening Targeting Efficiency in Human Pluripotent Stem Cells.
Bower OJ; McCarthy A; Lea RA; Alanis-Lobato G; Zohren J; Gerri C; Turner JMA; Niakan KK
Curr Protoc; 2021 Aug; 1(8):e232. PubMed ID: 34432381
[TBL] [Abstract][Full Text] [Related]
37. Efficient generation of hiPSC neural lineage specific knockin reporters using the CRISPR/Cas9 and Cas9 double nickase system.
Li S; Xue H; Long B; Sun L; Truong T; Liu Y
J Vis Exp; 2015 May; (99):e52539. PubMed ID: 26065872
[TBL] [Abstract][Full Text] [Related]
38. Generation of α-1,3-Galactosyltransferase-Deficient Porcine Embryonic Fibroblasts by CRISPR/Cas9-Mediated Knock-in of a Small Mutated Sequence and a Targeted Toxin-Based Selection System.
Sato M; Kagoshima A; Saitoh I; Inada E; Miyoshi K; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S
Reprod Domest Anim; 2015 Oct; 50(5):872-80. PubMed ID: 26138589
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
González F
Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
[TBL] [Abstract][Full Text] [Related]
40. Highly Efficient CRISPR/Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.
Maguire JA; Gadue P; French DL
Curr Protoc; 2022 Nov; 2(11):e590. PubMed ID: 36426905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]